FDA Panel Backs Using Bivalent Formula For Primary, Booster COVID Shots

By Lia DeGroot / January 26, 2023 at 8:36 PM
FDA’s vaccine advisers on Thursday (Jan. 26) voted unanimously in favor of harmonizing the COVID-19 vaccine primary series and booster doses so that the bivalent Omicron shots are administered as a primary series and the monovalent shots are essentially phased out. All 21 voting members at FDA’s Vaccines and Related Biological Products Committee meeting agreed that the change would simplify the vaccination process and more closely match vaccinations to the circulating strains of the virus. “There's so much confusion about...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.